Paper
6 February 2007 Design of programmable multilayered nanoparticles with in situ manufacture of therapeutic genes for nanomedicine
Mary-Margaret Seale, Emily Haglund, Christy L. Cooper, Lisa M. Reece, James F. Leary
Author Affiliations +
Abstract
Nanomedicine focuses on a new approach to diagnostic and therapeutic strategies. Nanomedical systems distinguish between diseased and healthy cells on a single cell level and perform a programmed function when necessary. Current research in nanomedicine investigates the interaction of nanomedical systems with living systems in order to assess the biological effects both in the short and long term. The unique goal of the nanomedical system is to deliver a gene for in situ manufacturing of therapeutic agents for cellular repair. Treating cells on an individual level illustrates a paradigm shift created from nanotechnology.
© (2007) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Mary-Margaret Seale, Emily Haglund, Christy L. Cooper, Lisa M. Reece, and James F. Leary "Design of programmable multilayered nanoparticles with in situ manufacture of therapeutic genes for nanomedicine", Proc. SPIE 6430, Advanced Biomedical and Clinical Diagnostic Systems V, 643003 (6 February 2007); https://doi.org/10.1117/12.701619
Lens.org Logo
CITATIONS
Cited by 4 scholarly publications.
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Nanoparticles

Nanomedicine

Magnetism

Manufacturing

Particles

Therapeutics

Cell death

Back to Top